相关实验视频
Updated: Jan 29, 2026

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
第三代抗精神病药物作为抗治疗强迫症障碍的增强:对有效性和耐受性的叙述性审查
Gianluca Rosso1,2, Stefano Peracchia1, Nicola Rizzo Pesci1,2
1Department of Neurosciences 'Rita Levi Montalcini', University of Torino, 10126 Turin, Italy.
第三代抗精神病药物 (TGA) 显示出增强治疗耐治疗强迫症 (OCD) 患者治疗的希望. 阿里皮普拉显示出显著的疗效,而布雷克斯皮普拉,卡里普拉和卢马特的证据正在出现.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 强迫症是一种慢性精神疾病,严重影响日常功能和生活质量.
- 强迫症中常见的是抗治疗性,因此需要探索新的治疗策略.
研究的目的:
- 为提供第三代抗精神病药物 (TGA) 作为选择性血清素再吸收抑制剂 (SRI) -耐药性强迫症的增强疗法进行最新的审查.
- 总结目前关于TGA在治疗耐药性强迫症治疗中的有效性和有用性的证据.
主要方法:
- 进行了对TGA治疗耐药性强迫症研究的叙述性综述.
- 用PubMed数据库进行文献搜索,仅包括人类参与者的英语研究.
主要成果:
- 在五份报告中,与安慰剂和其他抗精神病药物相比,阿里皮普拉的响应率很高.
- 布雷克西普拉在两个队列研究中显示出不同但高的响应率.
- 卡里普拉辛在一项队列研究中显示出61.5%的应答率,而卢马特佩龙在单个病例报告中显示出有效性.
结论:
- 第三代抗精神病药物 (TGA),特别是阿里皮普拉,在临床上对强迫症耐药性强迫症中增强SRI治疗有用.
- 虽然 cariprazine 和 lumateperone 的证据是有限的,但它有助于理解在强迫症治疗中TGA.
更多相关视频
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
09:14Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
Published on: March 14, 2025
相关概念视频
Obsessive-Compulsive Disorder
Personality Disorders: Dependent and Obsessive-Compulsive
Dependent Personality Disorder
Dependent personality disorder is characterized by an excessive reliance on others to manage various aspects of life. Individuals with this disorder often struggle...
Treatment Resistant Cancers
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview